Browsing Tag
Maryland
85 posts
Kroger (NYSE: KR) to reboot consolidation strategy with $1.65bn acquisition of Giant Eagle
Kroger (KR) to acquire Giant Eagle for $1.65B, adding 197 stores and $9B in sales across five states. First major deal since the Albertsons collapse.
Why the June 23 primaries could test Trump and Mamdani’s political power
Find out how the June 23 primaries could reshape Trump’s GOP power, Mamdani’s progressive push and the 2026 midterm map today!
Accenture bets $4.18bn on Dragos-led OT security platform as $ACN tumbles after forecast cut
Find out how Accenture’s $4.18bn Dragos, runZero and NetRise deals could reshape OT security, critical infrastructure and $ACN sentiment.
Dycom (NYSE: DY) surges 28% on record Q1 beat and data center pivot
Dycom built fiber for telecoms. Now hyperscalers are pulling it inside the data center fence, and a 56% revenue jump shows the pivot is working.
AlphaGen targets 2.7GW PJM power expansion as reliability pressure builds across U.S. grid
PJM needs capacity faster than new plants can be built. AlphaGen’s 2,700 MW plan tests whether existing sites can close the reliability gap.
Marketplace 4 Insurance adds Swann Insurance Agency in latest Mid-Atlantic growth move
Marketplace 4 Insurance has acquired Swann Insurance Agency in Maryland. Read how the deal expands Mid-Atlantic reach and what it could mean next.
Paris Baguette expands in Maryland with new Owings Mills café at Metro Centre
Paris Baguette is opening in Owings Mills at Metro Centre, adding a new traffic-driving tenant to the mixed-use project. Read what it means now.
Can First United Corporation (NASDAQ: FUNC) keep expanding core earnings despite OREO drag and rising deposit costs?
FUNC just posted record core earnings for 2025—but can it sustain margins as legacy loan losses reappear? Find out what’s next for First United Corporation.
Can PJM’s new rules for data center integration prevent a reliability shortfall across its 13-state grid?
PJM outlines new 2026 plan to manage large load growth and prevent grid shortfalls. Find out how data centers and LSEs must adapt under new rules.
GSK offloads Human Genome Sciences: what’s next for Samsung Biologics’ global ambitions?
Samsung Biologics acquires Human Genome Sciences from GSK for $280M, gaining its first U.S. biologics plant. Find out what this move means for global CDMO strategy.